ALA.M. Lakatosh

A.M. Lakatosh

*This is an algorithmically generated author record based on publicly available information.

A.M. Lakatosh has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Modern approaches to diagnosis and surgical delivery management in women with placenta previa after cesarean section depending on the presence of placenta accreta spectrum

    by V.V. Kaminsky, P.V. Lakatosh, V.P. Lakatosh, O.Y. Kostenko, A.M. Lakatosh, Y.M. Melnyk, M.I. Antonyuk

    Placenta previa (PP) after cesarean section (CS), when combined with placenta accreta spectrum (PAS), is associated with a high risk of blood loss, blood transfusion, and peripartum hysterectomy. Aim - to evaluate prenatal diagnosis of PAS in pregnant women with PP and a uterine scar after CS and to compare the outcomes of staged organ-preserving surgical intervention (CLAP) and peripartum hysterectomy. Materials and methods. Between 2022 and 2026, 145 pregnant women with PP after CS were examined: 66 with PP+PAS and 79 with PP without PAS. Risk factors and ultrasound (US) and magnetic resonance imaging (MRI) findings were assessed. The PP+PAS group was divided into the peripartum hysterectomy (n=36) and CLAP (n=30) subgroups. CLAP included CS above the placenta, bilateral internal iliac artery ligation, resection of the invasive area with metroplasty, and lower uterine segment compression using the KONIS suture. Blood loss, transfusion rates, and early neonatal outcomes were compared. Results. In the PP+PAS group, a history of hysteroscopy (22.7%), uterine curettage/vacuum aspiration (42.4%), and assisted reproductive technologies (13.6%) were more common. Loss of the retroplacental clear zone on US was detected in 87.9% of cases, while T2 dark bands on MRI were observed in 81.8%. CLAP reduced intraoperative blood loss (2437±562 mL vs. 3328±720 mL) and the transfusion rate (60.0% vs 86.1%) without worsening early neonatal outcomes. Conclusions. Comprehensive assessment of risk factors and US and MRI findings facilitates timely diagnosis of PAS. CLAP reduces blood loss and transfusion requirements, enables uterine preservation, and does not adversely affect early neonatal outcomes. The study was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent from women was obtained for the study. The authors declare that there is no conflict of interest.

  • Open Access

    Comparative analysis of neonatal outcomes in placenta previa and placenta previa with placenta accreta spectrum in women with uterine scar after previous cesarean section

    by V.V. Kaminsky, P.V. Lakatosh, A.M. Lakatosh, M.I. Antonyuk, Y.M. Melnyk, O.Y. Kostenko, V.P. Lakatosh

    The increasing rate of cesarean section (CS) has led to a higher risk of abnormal placentation. Placenta previa (PP) and its combination with placenta accreta spectrum (PP+PAS) in women with a uterine scar after previous CS are interrelated conditions that significantly affect neonatal outcomes. Aim - to compare neonatal outcomes in PP and PP+PAS in women with a uterine scar after prior CS. Materials and methods. A total of 205 pregnant women were examined in 2022-2025: Group I - PP without PAS (n=66), Group II - PP+PAS (n=79), and Group III - control without PP or PAS (n=60). Neonatal condition at birth, perinatal complications, rooming-in, and causes of neonatal death were analyzed. Statistical analysis was performed using Student's t-test and χ²; p<0.05. Results. The rate of emergency CS in the PP+PAS group was 32.9%. Mean birth weight was lower in PP+PAS (2610 g) than in PP (2890 g) and controls (3310 g), with lower Apgar scores. The incidence of complications in PP vs PP+PAS was: fetal distress 27.3% vs 43.0%; asphyxia 18.2% vs 36.7%; respiratory distress syndrome 21.2% vs 40.5%; hypoxic-ischemic encephalopathy 12.1% vs 26.6%; anemia 15.2% vs 31.6%; infectious complications 10.6% vs 22.8%. Transient disorders during rooming-in (low birth weight, hypoglycemia) occurred in PP in 9.1% and 15.1%, and in PP+PAS in 15.2% and 22.8%, respectively. PP+PAS was associated with a fivefold increase in neonatal mortality and severe outcomes. Conclusions. PP+PAS is associated with earlier delivery, a higher rate of emergency CS, poorer neonatal condition, and a fivefold increase in neonatal mortality, whereas mortality was minimal or absent in isolated PP and controls. The study was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent was obtained from all participants. The authors declare no conflict of interest.